Supreme Court of the United States
Skip Navigation LinksHome > Search Results



Docket for 24-889
RSS Feed Print Notify Me
Search documents in this case:
No. 24-889
Title:Hikma Pharmaceuticals USA Inc., et al., Petitioners
v.
Amarin Pharma, Inc., et al.
Docketed:February 19, 2025
Linked with 24A652
Lower Ct:United States Court of Appeals for the Federal Circuit
   Case Numbers:(2023-1169)
   Decision Date:June 25, 2024
   Rehearing Denied:October 17, 2024
  Discretionary Court Decision Date:

DateProceedings and Orders
Dec 27 2024Application (24A652) to extend the time to file a petition for a writ of certiorari from January 15, 2025 to February 14, 2025, submitted to The Chief Justice.
Main DocumentProof of Service
Jan 03 2025Application (24A652) granted by The Chief Justice extending the time to file until February 14, 2025.
Feb 14 2025Petition for a writ of certiorari filed. (Response due March 21, 2025)
PetitionAppendixProof of ServiceCertificate of Word Count

NAMEADDRESSPHONE
Attorneys for Petitioners
Charles Bennett Klein
    Counsel of Record
Winston & Strawn LLP
1901 L Street NW
Washington, DC 20036

cklein@winston.com
(202) 282-5000
Party name: Hikma Pharmaceuticals USA Inc. and Hikma Pharmaceuticals PLC
Attorneys for Respondents
Michael Robert Huston
    Counsel of Record
Perkins Coie LLP
2525 E. Camelback Road
Suite 500
Phoenix, AZ 85016

mhuston@perkinscoie.com
202-434-1630
Party name: Amarin Pharma, Inc., et al.

 

SUPREME COURT OF THE UNITED STATES 1 First Street, NE Washington, DC 20543